Samplix
About:
Samplix's Xdrop® technology is a proprietary droplet-based platform designed for single-molecule encapsulation.
Website: https://www.samplix.com/
Top Investors: European Innovation Council, EASME - EU Executive Agency for SMEs, Fjord Capital
Description:
Samplix has developed a proprietary technology - the Xdrop™ technology – for single molecule sample preparation. At the core of the technology is the generation of millions of droplets formed as “water-oil-water”, each droplet constituting a reaction chamber for the handling of single DNA molecules. The Xdrop™ technology comprises both an instrument and related consumables. Samplix enables single DNA molecule sample preparation where today only multi-molecule sample preparation is possible. Among many applications, the Xdrop™ technology allows for targeted enrichment of very large DNA fragments. Samplix addresses customers’ demand for precision, sensitivity and ease of use by overcoming the technical shortcomings of today's technologies.
12.7M EUR
$1M to $10M
Herlev, Hovedstaden, Denmark
2013-01-01
mjm(AT)samplix.com
Marie Mikkelsen
11-50
2023-03-30
Private
© 2025 bioDAO.ai